{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:07:45Z","timestamp":1793754465935,"version":"4.6.1"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Sarcoidosis is a systemic disease of unknown etiology, characterized by the presence of non-caseating granulomas in various organs, mainly the lungs, and the lymphatic system. Since the individualization of sarcoidosis-lymphoma association by Brincker et al., the relationship between sarcoidosis or granulomatous syndromes and malignancies has been clarified through observational studies worldwide. Two recent meta-analyses showed an increased risk of neoplasia in sarcoidosis. The granulomatosis can also reveal malignancy, either solid or hematological, defining paraneoplastic sarcoidosis. Recent cancer immunotherapies, including immune checkpoint inhibitors (targeting PD-1, PD-L1, or CTLA-4) and BRAF or MEK inhibitors were also reported as possible inducers of sarcoidosis-like reactions. Sarcoidosis and neoplasia, especially lymphoma, can show overlapping presentations, thus making the diagnosis and treatment harder to deal with. There are currently no formal recommendations to guide the differential diagnosis workup between the evolution of lymphoma or a solid cancer and a granulomatous reaction associated with neoplasia. Thus, in atypical presentations (e.g., deeply impaired condition, compressive lymphadenopathy, atypical localization, unexplained worsening lymphadenopathy, or splenomegaly), and treatment-resistant disease, targeted biopsies on suspect localizations with histological examination could help the clinician to differentiate neoplasia from sarcoidosis. Pathological diagnosis could sometimes be challenging since very few tumor cells may be surrounded by massive granulomatous reaction. The sensitization of currently available diagnostic tools should improve the diagnostic accuracy, such as the use of more \u201ccancer-specific\u201d radioactive tracers coupled with Positron Emission Tomography scan.<\/jats:p>","DOI":"10.3389\/fmed.2020.594118","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:26:02Z","timestamp":1606199162000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["Sarcoidosis and Cancer: A Complex Relationship"],"prefix":"10.3389","volume":"7","author":[{"given":"Thomas","family":"El Jammal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related Mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur Respir J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1164\/ajrccm.160.5.9904045","article-title":"Increased risk for cancer following sarcoidosis","volume":"160","author":"Askling","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/bjc.1972.18","article-title":"Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata","volume":"26","author":"Brincker","year":"1972","journal-title":"Br J Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/bjc.1974.64","article-title":"The incidence of malignant tumours in patients with respiratory sarcoidosis","volume":"29","author":"Brincker","year":"1974","journal-title":"Br J Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1183\/09031936.98.12040906","article-title":"Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients","volume":"12","author":"R\u00f8mer","year":"1998","journal-title":"Eur Respir J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0305-7372(86)90002-2","article-title":"Sarcoid reactions in malignant tumours","volume":"13","author":"Brincker","year":"1986","journal-title":"Cancer Treat Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.autrev.2020.102587","article-title":"Sarcoidosis related to checkpoint and BRAF\/MEK inhibitors in melanoma","volume":"19","author":"Rubio-Rivas","year":"2020","journal-title":"Autoimm Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-8722-3-35","article-title":"Autoimmune conditions and hairy cell leukemia: an exploratory case-control study","volume":"3","author":"Anderson","year":"2010","journal-title":"J Hematol Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00296-014-2983-5","article-title":"Sarcoidosis and the occurrence of malignant diseases","volume":"34","author":"Blank","year":"2014","journal-title":"Rheumatol Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/ijc.24261","article-title":"A cohort study of cancer among sarcoidosis patients","volume":"124","author":"Boffetta","year":"2009","journal-title":"Int J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/bjc.1986.199","article-title":"The sarcoidosis-lymphoma syndrome","volume":"54","author":"Brincker","year":"1986","journal-title":"Br J Cancer."},{"key":"B15","first-page":"31","article-title":"Coexistence of sarcoidosis and malignant disease: causality or coincidence?","volume":"6","author":"Brincker","year":"1989","journal-title":"Sarcoidosis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/annonc\/mdn767","article-title":"Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden","volume":"20","author":"Ji","year":"2009","journal-title":"Ann Oncol."},{"key":"B18","first-page":"598","article-title":"[Malignancies in patients with sarcoidosis]","volume":"30","author":"Kataoka","year":"1992","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3324\/haematol.2009.008094","article-title":"Autoimmunity and risk for Hodgkin's lymphoma by subtype","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case\u2013control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"JNCI."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","article-title":"The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"101","author":"Le Jeune","year":"2007","journal-title":"Respir Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/art.23267","article-title":"Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma","volume":"58","author":"Mellemkjaer","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/thx.52.10.892","article-title":"Risk of malignant neoplasms in patients with pulmonary sarcoidosis","volume":"52","author":"Seersholm","year":"1997","journal-title":"Thorax."},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"JNCI."},{"key":"B25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1183\/09031936.00084414","article-title":"Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study","volume":"45","author":"S\u00f8gaard","year":"2015","journal-title":"Eur Respir J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22941","article-title":"Risk of malignancy among patients with sarcoidosis: a population-based cohort study: sarcoidosis and risk of malignancy","volume":"69","author":"Ungprasert","year":"2017","journal-title":"Arthr Care Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/resp.12369","article-title":"Is the incidence of malignancy increased in patients with sarcoidosis? A systematic review and meta-analysis: malignancy and sarcoidosis","volume":"19","author":"Ungprasert","year":"2014","journal-title":"Respirology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1378\/chest.14-1475","article-title":"Sarcoidosis and cancer risk","volume":"147","author":"Bonifazi","year":"2015","journal-title":"Chest."},{"key":"B29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.43.7.516","article-title":"Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease","volume":"43","author":"Valeyre","year":"1988","journal-title":"Thorax."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.3892\/ol.2017.7247","article-title":"Coexistence of sarcoidosis and metastatic lesions: a diagnostic and therapeutic dilemma","volume":"14","author":"Spiekermann","year":"2017","journal-title":"Oncol Lett"},{"key":"B31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.revmed.2019.05.006","article-title":"Faut-il rechercher un cancer apr\u00e8s la d\u00e9couverte d'une granulomatose inexpliqu\u00e9e?","volume":"40","author":"Seve","year":"2019","journal-title":"La Revue de M\u00e9decine Interne."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jinf.2017.03.012","article-title":"Increased risk of active tuberculosis after cancer diagnosis","volume":"74","author":"Simonsen","year":"2017","journal-title":"J Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/pbc.20061","article-title":"Atypical mycobacterial infections in children with cancer","volume":"43","author":"Reilly","year":"2004","journal-title":"Pediatr Blood Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Medicine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s15010-001-2048-z","article-title":"Disseminated Nocardia asteroides presenting as pulmonary non-caseating granulomas in a patient with waldenstrom macroglobulinemia","volume":"30","author":"Apisarnthanarak","year":"2002","journal-title":"Infection."},{"key":"B37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0970-2113.184873","article-title":"Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience","volume":"33","author":"Singh","year":"2016","journal-title":"Lung India."},{"key":"B38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.anl.2018.12.006","article-title":"Post-transplantation laryngeal actinomycosis","volume":"46","author":"Sei","year":"2019","journal-title":"Auris Nasus Larynx."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/myc.13153","article-title":"Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation","volume":"63","author":"Nematollahi","year":"2020","journal-title":"Mycoses."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e00807","DOI":"10.1128\/IAI.00807-16","article-title":"Specific human and candida cellular interactions lead to controlled or persistent infection outcomes during granuloma-like formation","volume":"85","author":"Misme-Aucouturier","year":"2017","journal-title":"Infect Immun."},{"key":"B41","first-page":"499","article-title":"Orofacial aspergillosis in acute leukemia","volume":"59","author":"Dreizen","year":"1985"},{"key":"B42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/PAS.0b013e3181d9f16a","article-title":"Granulomatous reaction to Pneumocystis jirovecii: clinicopathologic review of 20 cases","volume":"34","author":"Hartel","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/j.ijid.2009.02.009","article-title":"Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases","volume":"13","author":"Peters","year":"2009","journal-title":"Int J Infect Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S423","DOI":"10.1093\/clinids\/17.Supplement_2.S423","article-title":"Toxoplasmosis in patients with cancer","volume":"17","author":"Israelski","year":"1993","journal-title":"Clin Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/jcp.56.11.850","article-title":"Hepatic granulomas: a 10 year single centre experience","volume":"56","author":"Gaya","year":"2003","journal-title":"J Clin Pathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1023\/B:DDAS.0000043366.18578.15","article-title":"Prevalence of hepatic granulomas in chronic hepatitis B","volume":"49","author":"Tahan","year":"2004","journal-title":"Dig Dis Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00277-018-3505-4","article-title":"Lymphomatoid granulomatosis mimicking cancer and sarcoidosis","volume":"98","author":"Alexandra","year":"2019","journal-title":"Ann Hematol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e227252","DOI":"10.1136\/bcr-2018-227252","article-title":"Multiple \u2018doughnut\u2019 granulomas in a liver transplant patient with CMV reactivation","volume":"11","author":"Dejhansathit","year":"2018","journal-title":"BMJ Case Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s001050050614","article-title":"Sarkoidose bei Interferon-alpha-Therapie","volume":"48","author":"Otte","year":"1997","journal-title":"Der Hautarzt."},{"key":"B51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer."},{"key":"B52","first-page":"18","article-title":"Donor-acquired sarcoidosis","volume":"19","author":"Padilla","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1183\/09031936.00189011","article-title":"Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis","volume":"41","author":"Bouvry","year":"2013","journal-title":"Eur Respir J."},{"key":"B54","first-page":"350","article-title":"Granulomatous lung disease in a patient with a family history of hematological disorders","volume":"31","author":"Overbeek","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000455877","article-title":"Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence?","volume":"93","author":"Arish","year":"2017","journal-title":"Respiration."},{"key":"B56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.revmed.2015.10.344","article-title":"Association lymphome et granulomatose : \u00e0 propos d'une s\u00e9rie de cas","volume":"37","author":"de Charry","year":"2016","journal-title":"La Revue de M\u00e9decine Interne."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1097\/MD.0000000000000121","article-title":"Sarcoidosis occurring after lymphoma: report of 14 patients and review of the literature","volume":"93","author":"London","year":"2014","journal-title":"Medicine."},{"key":"B58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/qjmed\/hcz207","article-title":"Paraneoplastic sarcoidosis: a review","volume":"113","author":"Herron","year":"2020","journal-title":"QJM."},{"key":"B59","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1001\/jama.233.8.886","article-title":"Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign?","volume":"233","author":"O'Connell","year":"1975","journal-title":"JAMA."},{"key":"B60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/1097-0142(197802)41:2<562::AID-CNCR2820410224>3.0.CO;2-X","article-title":"Epithelioid granulomas associated with Hodgkin's disease. Clinical correlations in 55 previously untreated patients","volume":"41","author":"Sacks","year":"1978","journal-title":"Cancer."},{"key":"B61","first-page":"420","article-title":"Histological study of immune parameters of regional lymph nodes of gastric cancer patients","volume":"73","author":"Takeuchi","year":"1982","journal-title":"Gan."},{"key":"B62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.lungcan.2009.03.001","article-title":"Sarcoidal reactions in regional lymph nodes of patients with non-small cell lung cancer: incidence and implications for minimally invasive staging with endobronchial ultrasound","volume":"66","author":"Steinfort","year":"2009","journal-title":"Lung Cancer."},{"key":"B63","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000334239","article-title":"Sarcoid-like granulomatosis and testicular germ cell tumor: the \u2018great imitator.\u2019","volume":"81","author":"Kaikani","year":"2011","journal-title":"Oncology"},{"key":"B64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<337::AID-CNCR18>3.0.CO;2-U","article-title":"Sarcoidosis and testicular carcinoma","volume":"83","author":"Rayson","year":"1998","journal-title":"Cancer."},{"key":"B65","first-page":"177","article-title":"Sarcoid reactions in primary pulmonary carcinoma: report of seven cases","volume":"5","author":"Kamiyoshihara","year":"1998","journal-title":"Oncol Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/jjco\/hyl141","article-title":"Surgical results of lung cancer with sarcoid reaction in regional lymph nodes","volume":"37","author":"Tomimaru","year":"2007","journal-title":"Jpn J Clin Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","author":"Cotliar","year":"2016","journal-title":"JAAD Case Rep."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2217\/imt-2018-0035","article-title":"Atezolizumab-induced sarcoid-like granulomatous reaction in a patient with urothelial cell carcinoma","volume":"10","author":"Mitchell","year":"2018","journal-title":"Immunotherapy."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1111\/ijd.14484","article-title":"First case of cutaneous sarcoidosis within tattoos under durvalumab","volume":"58","author":"Rousseau","year":"2019","journal-title":"Int J Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1159\/000502285","article-title":"Hypercalcaemia due to sarcoidosis during treatment with avelumab for metastatic Merkel cell carcinoma","volume":"12","author":"Tun Min","year":"2019","journal-title":"Case Rep Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1097\/MJT.0000000000000545","article-title":"Ipilimumab-induced sarcoidosis and thyroiditis","volume":"25","author":"Nandavaram","year":"2018","journal-title":"Am J Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000439400","article-title":"Sarcoidosis in patients treated with vemurafenib for metastatic melanoma: a paradoxical autoimmune activation","volume":"231","author":"Lheure","year":"2015","journal-title":"Dermatology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/CMR.0000000000000186","article-title":"Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib:","volume":"25","author":"Jansen","year":"2015","journal-title":"Melanoma Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1684\/ejd.2019.3640","article-title":"Atypical systemic sarcoid-like granulomatosis in two patients treated with BRAF and MEK inhibitors","volume":"29","author":"Assan","year":"2019","journal-title":"Eur J Dermatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart","year":"2019","journal-title":"J Int Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2020.02.024","article-title":"Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: increased rate and mimicker of metastasis","volume":"131","author":"Chorti","year":"2020","journal-title":"Eur J Cancer."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1095","DOI":"10.1097\/MD.0000000000001095","article-title":"Evaluation of mediastinal lymph nodes in sarcoidosis, sarcoid reaction, and malignant lymph nodes using CT and FDG-PET\/CT:","volume":"94","author":"Koo","year":"2015","journal-title":"Medicine"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"JCO."},{"key":"B80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40425-017-0300-z","article-title":"Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group","volume":"5","author":"Puzanov","year":"2017","journal-title":"J Immunother Cancer."},{"key":"B81","first-page":"161","article-title":"Possible transmission of sarcoidosis via allogenic bone marrow transplantation","volume":"14","author":"Heyll","year":"1994","journal-title":"Bone Marrow Transpl."},{"key":"B82","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/bmt.2008.340","article-title":"Donor cell-derived sarcoidosis after allogenic BMT","volume":"43","author":"Morita","year":"2009","journal-title":"Bone Marrow Transpl."},{"key":"B83","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1378\/chest.126.2.642","article-title":"Pulmonary sarcoidosis following stem cell transplantation","volume":"126","author":"Bhagat","year":"2004","journal-title":"Chest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1183\/09031936.00136112","article-title":"Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation","volume":"41","author":"Kushima","year":"2013","journal-title":"Eur Respir J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1080\/10428190500519410","article-title":"A mediastinal mass after donor lymphocyte infusion for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation","volume":"47","author":"Schattenberg","year":"2006","journal-title":"Leukem Lymphoma."},{"key":"B86","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.revmed.2017.01.001","article-title":"Sarcoidosis flare after autologous stem cell transplantation: an immune paradox?","volume":"38","author":"Marchal","year":"2017","journal-title":"Rev Med Interne."},{"key":"B87","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3109\/0284186X.2012.689854","article-title":"A case of sarcoidosis in a patient with testicular cancer post stem cell transplant","volume":"52","author":"Teo","year":"2013","journal-title":"Acta Oncologica."},{"key":"B88","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.bmt.1705606","article-title":"Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation","volume":"39","author":"Gooneratne","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B89","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Sem Arthr Rheum."},{"key":"B90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.36141\/svdld.v34i4.5817","article-title":"Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry","volume":"34","author":"Barba","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.36141\/svdld.v34i1.5368","article-title":"Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT","volume":"34","author":"Marquet","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.rmed.2018.02.009","article-title":"Efficacy and safety of infliximab biosimilar Inflectra \u00ae in severe sarcoidosis","volume":"138","author":"Schimmelpennink","year":"2018","journal-title":"Respir Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semarthrit.2011.12.006","article-title":"Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review","volume":"42","author":"Maneiro","year":"2012","journal-title":"Sem Arthr Rheum."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.semarthrit.2018.10.005","article-title":"Anti-tumor necrosis factor agents in sarcoidosis: a systematic review of efficacy and safety","volume":"48","author":"Adler","year":"2019","journal-title":"Sem Arthr Rheum."},{"key":"B95","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cyto.2016.09.013","article-title":"Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?","volume":"101","author":"Chen","year":"2018","journal-title":"Cytokine."},{"key":"B96","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/qjmed\/hcv039","article-title":"Sarcoidosis and lymphoma: a comparative study","volume":"108","author":"Chalayer","year":"2015","journal-title":"QJM."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1183\/09031936.00043010","article-title":"The relationship between sarcoidosis and lymphoma","volume":"36","author":"Papanikolaou","year":"2010","journal-title":"Eur Respir J."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1802470","DOI":"10.1183\/13993003.02470-2018","article-title":"Clinical differences in sarcoidosis patients with and without lymphoma: a single-centre retrospective cohort analysis","volume":"54","author":"Cerri","year":"2019","journal-title":"Eur Respir J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/ar3729","article-title":"How does BAFF activate B cells in patients with autoimmune diseases?","volume":"14","author":"Mariette","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.resmer.2019.09.002","article-title":"Diagnosis issues in sarcoidosis","volume":"77","author":"Jeny","year":"2020","journal-title":"Respir Med Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2214\/ajr.182.1.1820015","article-title":"Imaging manifestations of abdominal sarcoidosis","volume":"182","author":"Warshauer","year":"2004","journal-title":"Am J Roentgenol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.amjmed.2018.12.030","article-title":"Clinical characteristics and etiologies of miliary nodules in the US: a single-center study","volume":"132","author":"Salahuddin","year":"2019","journal-title":"Am J Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3949\/ccjm.84a.16108","article-title":"Sarcoidosis mimicking lytic osseous metastases","volume":"84","author":"Brandy-Garc\u00eda","year":"2017","journal-title":"CCJM."},{"key":"B105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3348\/kjr.2009.10.6.623","article-title":"Typical and atypical manifestations of intrathoracic sarcoidosis","volume":"10","author":"Park","year":"2009","journal-title":"Korean J Radiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1148\/rg.306105512","article-title":"Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation","volume":"30","author":"Criado","year":"2010","journal-title":"RadioGraphics."},{"key":"B107","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.revmed.2007.10.005","article-title":"Sarco\u00efdose \u00e0 pr\u00e9sentation atypique","volume":"29","author":"Bouvry","year":"2008","journal-title":"La Revue de M\u00e9decine Interne."},{"key":"B108","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/TCRM.S192922","article-title":"Refractory sarcoidosis: a review","volume":"16","author":"El Jammal","year":"2020","journal-title":"TCRM."},{"key":"B109","first-page":"2772","article-title":"Hodgkin's lymphoma with marked granulomatous reaction: a diagnostic pitfall","volume":"12","author":"Du","year":"2019","journal-title":"Int J Clin Exp Pathol."},{"key":"B110","first-page":"9593","article-title":"Classical Hodgkin lymphoma with necrotic granuloma-like morphological features","volume":"11","author":"Hou","year":"2018","journal-title":"Int J Clin Exp Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14740\/jh607","article-title":"diagnostic dilemma: an unusual case of angioimmunoblastic T-cell lymphoma manifesting as bone marrow non-caseating granuloma","volume":"9","author":"Bhatlapenumarthi","year":"2020","journal-title":"J Hematol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis\u2014a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"B113","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM198201143060203","article-title":"Lymphomatoid granulomatosis: prospective clinical and therapeutic experience over 10 years","volume":"306","author":"Fauci","year":"1982","journal-title":"N Engl J Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1148\/rg.2018180053","article-title":"PET\/CT in the diagnosis and workup of sarcoidosis: focus on atypical manifestations","volume":"38","author":"Akaike","year":"2018","journal-title":"RadioGraphics."},{"key":"B115","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.remn.2012.03.002","article-title":"Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET\/CT resembling an early recurrence of Hodgkin's Lymphoma","volume":"31","author":"Fallanca","year":"2012","journal-title":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5282698","article-title":"Diagnostic performance of PET or PET\/CT with different radiotracers in patients with suspicious lung cancer or pleural tumours according to published meta-analyses","volume":"2020","author":"Lococo","year":"2020","journal-title":"Contrast Med Mol Imaging."},{"key":"B117","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1754-9485.2011.02287.x","article-title":"Dual-time-point 18F-FDG-PET\/CT imaging in the assessment of suspected malignancy: Dual-time-point PET\/CT in malignancy","volume":"55","author":"Chan","year":"2011","journal-title":"J Med Imaging Radiat Oncol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/ccr3.1816","article-title":"Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature","volume":"6","author":"Gamperl","year":"2018","journal-title":"Clin Case Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3332\/ecancer.2015.537","article-title":"Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET\/CT: problem solving by diffusion whole-body MRI","volume":"9","author":"Conte","year":"2015","journal-title":"ecancer."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.594118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:26:10Z","timestamp":1606199170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.594118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":119,"alternative-id":["10.3389\/fmed.2020.594118"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.594118","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"article-number":"594118"}}